Here is a summary of scientific news briefs.
Exclusive-Polish gene project set to ditch Chinese tech over data glitches
A European Union-funded project to build a genomic map of Poland plans to ditch the gene sequencing technology of Chinese group BGI due to concerns about data security, one of the officials told Reuters. project. Concerns over Poland’s genomic map stem from questions about the use of Polish genomic data related to national security, said Marek Figlerowicz, professor at the Institute of Bioorganic Chemistry at the Polish Academy of Sciences who is leading the project. .
Severe COVID-19 can trigger autoimmune diseases; New variants cause more viruses in the air
The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the results and that has not yet been certified by peer review. Severe COVID-19 can ‘trigger’ immune self-attacks
Good Friends and Fresh Blood: The Social Life of a Vampire Bat
When you think of vampire bats, friendship and cooperation might not be among the qualities that come to mind for these blood-feasting creatures of the night. But maybe they should. Scientists on Thursday provided a deeper understanding of the social relationships between vampire bats, showing how those who have forged “friendship” -like bonds with others will meet these friends while seeking a meal.
Genetic study reveals how ancient sailors settled in vast Polynesia
Over a millennium ago, intrepid sailors crossed vast swathes of the Pacific Ocean in double-hulled canoes to reach the distant islands of Polynesia, the last habitable region on the planet to be colonized by the man. A genetic study published on Wednesday deciphered the timing and sequence of this colony from an area covering about a third of the Earth’s surface, with Samoa as the starting point while Rapa Nui, also known as Easter Island, and other places known for their megalithic statues were among the last to be reached.
AstraZeneca Invests in Imperial’s Self-Amplifying RNA Technology with Eye on Future Drugs
AstraZeneca Plc on Thursday reached an agreement with the company behind the experimental COVID-19 vaccine at Imperial College London to develop and sell drugs based on its self-amplifying RNA technology platform in other pathological areas. As part of the deal, VaxEquity, a startup founded by imperial vaccinologist Robin Shattock, could receive up to $ 195 million if certain milestones are met, in addition to royalties on approved drugs and equity investments from AstraZeneca and life sciences investor Morningside Ventures.
(This story was not edited by Devdiscourse staff and is auto-generated from a syndicated feed.)